GCEIP 500 Global rank #99 · United States
Bristol Myers Squibb: biopharmaceuticals and the business behind its reach
Bristol Myers Squibb researches and sells medicines in oncology, hematology, immunology and cardiovascular care.
The company
What it does
Bristol Myers Squibb operates in biopharmaceuticals. Its business model, products and customers connect it to a wider market, with the company’s own disclosures providing the basis for understanding its activities and reach.
Across markets
The company’s treatments reach patients through clinical practice and health systems across many countries. A medicine’s contribution depends on clinical evidence, safety, affordability and access; company revenue alone cannot describe patient benefit.
The company’s footprint and context are linked to the public sources below.
GCEIP view
What the record tells us
GCEIP sees its business impact in translating research into treatments used in routine care. Continued contribution depends on clinical results and the ability of patients to obtain the medicines they need.
Published recognition
Selected results
See published awards and company-list results 1 sources
- TIME100 Most Influential Companies · 2023View source
Leaders
Drug research